Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Emergency Medicine Journal : EMJ|April 22, 2024
Programme theories to describe how different general practitioner service models work in different contexts in or alongside emergency departments (GP-ED): realist evaluationAlison Cooper, Michelle Edwards, Freya Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2022
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant MelanomaReinhard Dummer, Keith T Flaherty, Caroline Robert, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative studyElin Baddeley, Carme Font, Isabelle Mahé, et al.
Thrombosis Research|July 12, 2025
"Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancerElin Baddeley, Carme Font, Isabelle Mahé, et al.
Future Oncology (London, England)|June 13, 2023
COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAFReinhard Dummer, Keith T Flaherty, Caroline Robert, et al.
Health and Social Care Delivery Research|April 30, 2024
Evaluation of different models of general practitioners working in or alongside emergency departments: a mixed-methods realist evaluationFreya Davies, Michelle Edwards, Delyth Price, et al.
Trials|October 22, 2021
A lived experience co-designed study protocol for a randomised control trial: the Attempted Suicide Short Intervention Program (ASSIP) or Brief Cognitive Behavioural Therapy as additional interventions after a suicide attempt compared to a standard Suicide Prevention Pathway (SPP)Nicolas J C Stapelberg, Candice Bowman, Sabine Woerwag-Mehta, et al.
Thrombosis Research|January 18, 2026
Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study, Isabelle Mahé, Skerdi Haviari, et al.
Thrombosis and Haemostasis|January 24, 2025
Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting DiseaseEva K Kempers, Chantal Visser, Eric C T Geijteman, et al.
Hemasphere|May 20, 2025
Quality of vitamin K antagonist treatment during the last year of lifeChantal Visser, Eva K Kempers, Jamilla Goedgebuur, et al.
Pageof 8